The purpose of this study is to assess the safety, tolerability, pharmacokinetics, and
pharmacodynamics of multiple ascending oral doses of IA-14069 in healthy subjects and in
patients with RA on stable dosese of MTX, with preliminary assessment of efficacy in RA
patients.